{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:25:55Z","timestamp":1789709155860,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,15]]},"DOI":"10.7759\/cureus.39029","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:30:54Z","timestamp":1684153854000},"source":"Crossref","is-referenced-by-count":12,"title":["Antibiotics Associated With Clostridium difficile Infection"],"prefix":"10.7759","author":[{"given":"Abdur","family":"Rafey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqana","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memoona","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summiya","family":"Nizamuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa FC","year":"2015","unstructured":"Lessa FC, Mu Y, Bamberg WM, et al.. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015, 372:825-34. 10.1056\/NEJMoa1408913","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s1286-4579(99)80054-9","article-title":"Antibiotics and Clostridium difficile","volume":"1","author":"Freeman J","year":"1999","unstructured":"Freeman J, Wilcox MH. Antibiotics and Clostridium difficile. Microbes Infect. 1999,  1:377-84. 10.1016\/s1286-4579(99)80054-9","journal-title":"Microbes Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(09)70012-3","article-title":"New trends in Clostridium difficile virulence and pathogenesis","volume":"33","author":"Den\u00e8ve C","year":"2009","unstructured":"Den\u00e8ve C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents. 2009, 33:24-8. 10.1016\/S0924-8579(09)70012-3","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2017.03.004","article-title":"Inhibition of spore germination, growth, and toxin activity of clinically relevant C.\u00a0difficile strains by gut microbiota derived secondary bile acids","volume":"45","author":"Thanissery R","year":"2017","unstructured":"Thanissery R, Winston JA, Theriot CM. Inhibition of spore germination, growth, and toxin activity of clinically relevant C.\u00a0difficile strains by gut microbiota derived secondary bile acids. Anaerobe. 2017, 45:86-100. 10.1016\/j.anaerobe.2017.03.004","journal-title":"Anaerobe"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2015.10.009","article-title":"Virulence factors of Clostridium difficile and their role during infection","volume":"37","author":"Janoir C","year":"2016","unstructured":"Janoir C. Virulence factors of Clostridium difficile and their role during infection. Anaerobe. 2016, 37:13-24. 10.1016\/j.anaerobe.2015.10.009","journal-title":"Anaerobe"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald LC","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, et al.. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005, 353:2433-41. 10.1056\/NEJMoa051590","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo VG","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, et al.. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005, 353:2442-9. 10.1056\/NEJMoa051639","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.3.476","article-title":"Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982","volume":"151","author":"Aronsson B","year":"1985","unstructured":"Aronsson B, M\u00f6llby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis. 1985, 151:476-81. 10.1093\/infdis\/151.3.476","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/23.6.929","article-title":"Extended spectrum cephalosporins and Clostridium difficile","volume":"23","author":"Golledge CL","year":"1989","unstructured":"Golledge CL, McKenzie T, Riley TV. Extended spectrum cephalosporins and Clostridium difficile. J Antimicrob Chemother. 1989, 23:929-31. 10.1093\/jac\/23.6.929","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7016.1345","article-title":"Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime","volume":"311","author":"Impallomeni M","year":"1995","unstructured":"Impallomeni M, Galletly NP, Wort SJ, Starr JM, Rogers TR. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. BMJ. 1995, 311:1345-6. 10.1136\/bmj.311.7016.1345","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46 Suppl 1","author":"Owens RC Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008, 46 Suppl 1:S19-31. 10.1086\/521859","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/28.6.578","article-title":"An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea","volume":"28","author":"Ludlam H","year":"1999","unstructured":"Ludlam H, Brown N, Sule O, Redpath C, Coni N, Owen G. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. Age Ageing. 1999, 28:578-80. 10.1093\/ageing\/28.6.578","journal-title":"Age Ageing"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/342691","article-title":"Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy","volume":"35","author":"Thomas C","year":"2002","unstructured":"Thomas C, Stevenson M, Williamson DJ, Riley TV. Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clin Infect Dis. 2002, 35:1457-62. 10.1086\/342691","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr253","article-title":"Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection","volume":"66","author":"Talpaert MJ","year":"2011","unstructured":"Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011, 66:2168-74. 10.1093\/jac\/dkr253","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens V","year":"2011","unstructured":"Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011, 53:42-8. 10.1093\/cid\/cir301","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2014.08.015","article-title":"Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China","volume":"30","author":"Huang H","year":"2014","unstructured":"Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. 2014, 30:65-9. 10.1016\/j.anaerobe.2014.08.015","journal-title":"Anaerobe"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.02.001","article-title":"Involvement of bacteria other than Clostridium difficile in antibiotic-associated diarrhoea","volume":"24","author":"Larcombe S","year":"2016","unstructured":"Larcombe S, Hutton ML, Lyras D. Involvement of bacteria other than Clostridium difficile in antibiotic-associated diarrhoea. Trends Microbiol. 2016, 24:463-76. 10.1016\/j.tim.2016.02.001","journal-title":"Trends Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176797","article-title":"The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact","volume":"12","author":"Borren NZ","year":"2017","unstructured":"Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN. The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact. PLoS One. 2017, 12:e0176797. 10.1371\/journal.pone.0176797","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald LC","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al.. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018, 66:e1-e48. 10.1093\/cid\/cix1085","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1674-8301(10)60055-3","article-title":"Clostridium difficile infections in China","volume":"24","author":"Jin K","year":"2010","unstructured":"Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. J Biomed Res. 2010, 24:411-6. 10.1016\/S1674-8301(10)60055-3","journal-title":"J Biomed Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.008","article-title":"Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia","volume":"73","author":"Chalmers JD","year":"2016","unstructured":"Chalmers JD, Akram AR, Singanayagam A, Wilcox MH, Hill AT. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect. 2016, 73:45-53. 10.1016\/j.jinf.2016.04.008","journal-title":"J Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2013.08.003","article-title":"Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization","volume":"48","author":"Lin HJ","year":"2015","unstructured":"Lin HJ, Hung YP, Liu HC, et al.. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization. J Microbiol Immunol Infect. 2015, 48:183-9. 10.1016\/j.jmii.2013.08.003","journal-title":"J Microbiol Immunol Infect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.07.010417","article-title":"Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis","volume":"7","author":"Eze P","year":"2017","unstructured":"Eze P, Balsells E, Kyaw MH, Nair H. Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis. J Glob Health. 2017, 7:010417. 10.7189\/jogh.07.010417","journal-title":"J Glob Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.1.109","article-title":"Clostridium difficile infection associated with antineoplastic chemotherapy: a review","volume":"17","author":"Anand A","year":"1993","unstructured":"Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993, 17:109-13. 10.1093\/clinids\/17.1.109","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s1413-8670(12)70320-3","article-title":"Clinical risk factors for Clostridium difficile-associated diseases","volume":"16","author":"Min CS","year":"2012","unstructured":"Min CS, Joon LJ, Jung YH. Clinical risk factors for Clostridium difficile-associated diseases. Braz J Infect Dis. 2012, 16:256-61. 10.1016\/s1413-8670(12)70320-3","journal-title":"Braz J Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: review","volume":"38","author":"Czepiel J","year":"2019","unstructured":"Czepiel J, Dr\u00f3\u017cd\u017c M, Pituch H, et al.. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019, 38:1211-21. 10.1007\/s10096-019-03539-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2009.01274.x","article-title":"Chronic kidney disease as a risk factor for Clostridium difficile infection","volume":"15","author":"Eddi R","year":"2010","unstructured":"Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton). 2010, 15:471-5. 10.1111\/j.1440-1797.2009.01274.x","journal-title":"Nephrology (Carlton)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155016-antibiotics-associated-with-clostridium-difficile-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:30Z","timestamp":1707508830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155016-antibiotics-associated-with-clostridium-difficile-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.39029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}